129 related articles for article (PubMed ID: 37357526)
1. METTL16 promotes osteosarcoma progression by downregulating VPS33B in an m
Cheng J; Xu Z; Tan W; He J; Pan B; Zhang Y; Deng Y
J Cell Physiol; 2024 Mar; 239(3):e31068. PubMed ID: 37357526
[TBL] [Abstract][Full Text] [Related]
2. The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1.
Miao W; Chen J; Jia L; Ma J; Song D
Biochem Biophys Res Commun; 2019 Aug; 516(3):719-725. PubMed ID: 31253399
[TBL] [Abstract][Full Text] [Related]
3. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).
Wei K; Gao Y; Wang B; Qu YX
Bioengineered; 2022 Mar; 13(3):5236-5250. PubMed ID: 35156522
[TBL] [Abstract][Full Text] [Related]
4. METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m
Dai YZ; Liu YD; Li J; Chen MT; Huang M; Wang F; Yang QS; Yuan JH; Sun SH
Cell Mol Biol Lett; 2022 May; 27(1):41. PubMed ID: 35596159
[TBL] [Abstract][Full Text] [Related]
5. m6A-dependent up-regulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma.
Ling Z; Chen L; Zhao J
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32266933
[TBL] [Abstract][Full Text] [Related]
6. VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma.
Liang Z; Liu Z; Cheng C; Wang H; Deng X; Liu J; Liu C; Li Y; Fang W
Cell Death Dis; 2019 Apr; 10(4):305. PubMed ID: 30944308
[TBL] [Abstract][Full Text] [Related]
7. VPS33B interacts with NESG1 to suppress cell growth and cisplatin chemoresistance in ovarian cancer.
Ning Y; Zeng Z; Deng Y; Feng W; Huang L; Liu H; Lin J; Zhang C; Fan Y; Liu L
Cancer Sci; 2021 May; 112(5):1785-1797. PubMed ID: 33788346
[TBL] [Abstract][Full Text] [Related]
8. METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression.
Wei W; Zhang ZY; Shi B; Cai Y; Zhang HS; Sun CL; Fei YF; Zhong W; Zhang S; Wang C; He B; Jiang GM; Wang H
J Exp Clin Cancer Res; 2023 Jun; 42(1):151. PubMed ID: 37340443
[TBL] [Abstract][Full Text] [Related]
9. METTL16-mediated N6-methyladenosine modification of Soga1 enables proper chromosome segregation and chromosomal stability in colorectal cancer.
Li J; Yang F; Wang Z; Zheng S; Zhang S; Wang C; He B; Wang JB; Wang H
Cell Prolif; 2024 May; 57(5):e13590. PubMed ID: 38084791
[TBL] [Abstract][Full Text] [Related]
10. The RNA methyltransferase METTL16 enhances cholangiocarcinoma growth through PRDM15-mediated FGFR4 expression.
Liu N; Zhang J; Chen W; Ma W; Wu T
J Exp Clin Cancer Res; 2023 Oct; 42(1):263. PubMed ID: 37817227
[TBL] [Abstract][Full Text] [Related]
11. N
Ren Z; Hu Y; Sun J; Kang Y; Li G; Zhao H
Bioengineered; 2022 Apr; 13(4):7963-7973. PubMed ID: 35356854
[TBL] [Abstract][Full Text] [Related]
12. METTL16 promotes cell proliferation by up-regulating cyclin D1 expression in gastric cancer.
Wang XK; Zhang YW; Wang CM; Li B; Zhang TZ; Zhou WJ; Cheng LJ; Huo MY; Zhang CH; He YL
J Cell Mol Med; 2021 Jul; 25(14):6602-6617. PubMed ID: 34075693
[TBL] [Abstract][Full Text] [Related]
13. Fat mass and obesity associated (FTO)-mediated N6-methyladenosine modification of Krüppel-like factor 3 (KLF3) promotes osteosarcoma progression.
Shan HJ; Gu WX; Duan G; Chen HL
Bioengineered; 2022 Apr; 13(4):8038-8050. PubMed ID: 35311620
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of TBRG4 suppresses proliferation, invasion and promotes apoptosis of osteosarcoma cells by downregulating TGF-β1 expression and PI3K/AKT signaling pathway.
Huang F; Zhou P; Wang Z; Zhang XL; Liao FX; Hu Y; Chang J
Arch Biochem Biophys; 2020 Jun; 686():108351. PubMed ID: 32240636
[TBL] [Abstract][Full Text] [Related]
15. m
Wang A; Sun Y; Wang X; Yan Z; Wang D; Zeng L; Lu Q
Aging (Albany NY); 2023 Aug; 15(16):8444-8457. PubMed ID: 37647025
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-373 Promotes Growth and Cellular Invasion in Osteosarcoma Cells by Activation of the PI3K/AKT-Rac1-JNK Pathway: The Potential Role in Spinal Osteosarcoma.
Liu Y; Cheng Z; Pan F; Yan W
Oncol Res; 2017 Jul; 25(6):989-999. PubMed ID: 28244849
[TBL] [Abstract][Full Text] [Related]
17. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5.
Ye F; Tian L; Zhou Q; Feng D
Gene; 2019 Dec; 721():144093. PubMed ID: 31473323
[TBL] [Abstract][Full Text] [Related]
18. WTAP promotes osteosarcoma tumorigenesis by repressing HMBOX1 expression in an m
Chen S; Li Y; Zhi S; Ding Z; Wang W; Peng Y; Huang Y; Zheng R; Yu H; Wang J; Hu M; Miao J; Li J
Cell Death Dis; 2020 Aug; 11(8):659. PubMed ID: 32814762
[TBL] [Abstract][Full Text] [Related]
19. Human METTL16 is a
Warda AS; Kretschmer J; Hackert P; Lenz C; Urlaub H; Höbartner C; Sloan KE; Bohnsack MT
EMBO Rep; 2017 Nov; 18(11):2004-2014. PubMed ID: 29051200
[No Abstract] [Full Text] [Related]
20. METTL16 suppressed the proliferation and cisplatin-chemoresistance of bladder cancer by degrading PMEPA1 mRNA in a m6A manner through autophagy pathway.
Yu H; Zhuang J; Zhou Z; Song Q; Lv J; Yang X; Yang H; Lu Q
Int J Biol Sci; 2024; 20(4):1471-1491. PubMed ID: 38385084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
